Puma Biotechnology targets $192M-$198M NERLYNX revenue for 2025 amid strategic efforts

MT HANNACH
0 Min Read
Disclosure: This website may contain affiliate links, which means I may earn a commission if you click on the link and make a purchase. I only recommend products or services that I personally use and believe will add value to my readers. Your support is appreciated!

Puma Biotechnology targets $ 192 million – $ $ Return Nerlynx for 2025 in the midst of strategic efforts

Share This Article
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *